Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

10,251 total articles

Enerflex Ltd. Publishes 2026 Investor Update Presentation

Enerflex Ltd. Publishes 2026 Investor Update Presentation

Enerflex Ltd. has published its 2026 Investor Update presentation focusing on its strategy to prioritize operational excellence, targeted growth in attractive natural gas and power markets, and disciplined capital allocation. The company aims to improve adjusted EBITDA margin, cash conversion ratio, and ROCE by over 200 basis points over a full cyc…

Colliers completes acquisition of Ayesa Engineering

Colliers completes acquisition of Ayesa Engineering

Colliers has successfully acquired Ayesa Engineering, a global multidisciplinary engineering and project management firm based in Spain. This acquisition boosts Colliers Engineering's workforce to over 11,000 professionals across 23 countries and enhances its capabilities in property, infrastructure, water, and environmental sectors. The move under…

Agomab Announces Results of Annual General Meeting

Agomab Announces Results of Annual General Meeting

Agomab Therapeutics NV, a clinical-stage biopharmaceutical company listed on Nasdaq, announced at its Annual General Meeting on May 26, 2026, that all agenda items were approved, including approval of financial statements for 2025, discharge of board members and auditors, and reappointments to the Board of Directors. The company focuses on developi…

Aligos Therapeutics Presents Positive Data at the EASL Congress 2026

Aligos Therapeutics Presents Positive Data at the EASL Congress 2026

Aligos Therapeutics announced positive Phase 1 long-term follow-up data for pevifoscorvir sodium, demonstrating sustained reduction in hepatitis B viral markers and potential reduction of the cccDNA reservoir. Additionally, preclinical data showed synergistic antiviral effects with the ASO ALG-170675, supporting development of functional cure regim…

argenx to Present at Upcoming Investor Conferences

argenx to Present at Upcoming Investor Conferences

argenx announced its participation in two prominent investor conferences in June 2026, including the William Blair 46th Annual Growth Stock Conference and the Goldman Sachs 47th Annual Global Healthcare Conference. The presentations will highlight the company’s progress in immunology and its pipeline of novel antibody-based medicines targeting seve…

Disciplined Growth Acquisition Corporation Announces Pricing of $150 Million Initial Public Offering

Disciplined Growth Acquisition Corporation Announces Pricing of $150 Million Initial Public Offering

Disciplined Growth Acquisition Corporation, a blank check SPAC, has priced an initial public offering of 15 million units at $10 per unit, raising $150 million. The units comprise Class A ordinary shares and rights to additional shares post business combination, with expected listing on the NYSE under DGACU. The company aims to identify merger targ…

SQM Reports Earnings for the Three Months Ended March 31, 2026

SQM Reports Earnings for the Three Months Ended March 31, 2026

Sociedad Química y Minera de Chile S.A. (SQM) posted robust financial results for Q1 2026 with revenues rising 69.8% year-over-year to $1.76 billion and net income increasing 165.2% to $364.7 million. Strong lithium demand led to increased sales volumes and an upgrade of full-year sales guidance from 10% to 15%. The partnership with CODELCO through…

MediciNova Announces Completion of Last Patient Last Visit in the MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)

MediciNova Announces Completion of Last Patient Last Visit in the MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)

MediciNova, Inc. announced the completion of the last patient last visit in its Phase 2 clinical trial (MN-001-NATG-202) evaluating MN-001 (tipelukast) for treatment of hypertriglyceridemia and nonalcoholic fatty liver disease (NAFLD) associated with type 2 diabetes mellitus (T2DM). The randomized, placebo-controlled trial assessed MN-001's efficac…

Agora, Inc. Reports First Quarter 2026 Financial Results

Agora, Inc. Reports First Quarter 2026 Financial Results

Agora, Inc. announced Q1 2026 financial results showing 13.5% revenue growth year-over-year to $37.7 million and its sixth consecutive quarter of GAAP profitability with net income of $1.1 million. The company launched Agent Studio, a no-code voice AI platform, driving customer adoption and platform usage growth. Despite a slight margin decline due…

Genco Shipping & Trading Limited Sets the Record Straight on Numerous Falsehoods in Diana’s Investor Presentation

Genco Shipping & Trading Limited Sets the Record Straight on Numerous Falsehoods in Diana’s Investor Presentation

Genco Shipping & Trading Limited publicly refutes the allegations and misleading claims made by Diana Shipping Inc. in its recent investor presentation amid an ongoing hostile takeover attempt. Genco maintains that Diana's $23.50 per share tender offer undervalues the company and urges shareholders to vote for its current board and reject Diana's n…

IREN Targets $4.4bn in ARR with Blackwell Deployment at Childress

IREN Targets $4.4bn in ARR with Blackwell Deployment at Childress

IREN Limited announces a $1.6 billion purchase agreement with Dell for Blackwell AI systems as part of a $3.4 billion AI cloud contract. The deployment at its Childress, Texas data center is expected to increase IREN's annualized run-rate revenue from $3.7 billion to $4.4 billion upon commissioning in early 2027. This reflects IREN's strategy to ac…

Vestand Receives Nasdaq Staff Determination Notification Regarding Late 10-Q and 10-K Filings and Continued Listing Requirements

Vestand Receives Nasdaq Staff Determination Notification Regarding Late 10-Q and 10-K Filings and Continued Listing Requirements

Vestand Inc. has received a Nasdaq Staff Delisting Determination due to failure to file required SEC reports (10-Q and 10-K) on time. While trading suspension or delisting is not immediate, the company is appealing the decision and working to file the delinquent reports promptly. The outcome remains uncertain and could lead to delisting if complian…

Brookfield Corporation and Brookfield Wealth Solutions Receive Board Approval for Corporate Simplification

Brookfield Corporation and Brookfield Wealth Solutions Receive Board Approval for Corporate Simplification

Brookfield Corporation (BN) and Brookfield Wealth Solutions (BWS) have received board approval to merge their corporate structures into a single publicly traded company, Brookfield Corporation Ltd., listed on NYSE and TSX under the ticker BN. The transaction involves a one-for-one share exchange and aims to streamline the organization, maintain tax…

Osisko Development Announces Closing of US$225.0 Million Aggregate Principal Amount of 4.125% Convertible Senior Notes Offering

Osisko Development Announces Closing of US$225.0 Million Aggregate Principal Amount of 4.125% Convertible Senior Notes Offering

Osisko Development Corp. has completed a $225 million private placement of 4.125% convertible senior notes due 2031, with net proceeds aimed at advancing the Cariboo Gold Project and general corporate purposes. The offering includes an option for initial purchasers to buy additional notes and a concurrent $50 million affiliate purchase. Convertible…

NANOBIOTIX Announces Closing of Global Offering

NANOBIOTIX Announces Closing of Global Offering

Nanobiotix successfully closed a global offering raising approximately $100 million through the issuance of ordinary shares and pre-funded warrants, including additional American Depositary Shares (ADSs). The net proceeds will primarily fund the advancement of its Nanoprimer and other nanotechnology platforms (50-60%), support development of its le…

Dentsply Sirona Continues to Expand U.S. Distribution Network to Strengthen Access to its Digital Dentistry Solutions Across Key Regional Markets

Dentsply Sirona Continues to Expand U.S. Distribution Network to Strengthen Access to its Digital Dentistry Solutions Across Key Regional Markets

Dentsply Sirona has announced an expansion of its U.S. distribution network by partnering with Nashville Dental, Inc. (NDI) to include its full range of connected digital dentistry solutions in a nine-state territory across the Southeast and Mid-Atlantic regions. This move supports the company's strategy to improve customer accessibility and adopti…